CORE Team
Every member of the MIA team is a volunteer. Their expertise spans pediatrics, genetics, pharmacy, physiotherapy, law and administration.
Since January 2021, Menkes International Association (MIa) has been working to provide elesclomol-copper treatment to Menkes patients worldwide. This groundbreaking treatment, first tested successfully on a young boy named Marco, has brought hope to children suffering from this devastating disease. With the approval of national medical authorities, MIa is coordinating access to elesclomol-copper treatment, and six cases are currently underway.
CORE is the pharma-clinical team of Menkes International that carries out the follow-up of the exceptional treatments of the Menkes patients treated with elesclomol-copper by supporting local medical teams and providing clinical management advice.
Francesc Palau
Core Coordinator (ad interim) · Chair, Copper(less) Committee
Pediatrician & Clinical Geneticist, SJD Distinguished Research Fellow
Barcelona, Spain
Elena Godoy
Attending Pediatrician
Complex Chronic Children and Palliative Care Unit, Regional University Hospital
Málaga, Spain
Marta Duero
Chief Pharmacist
Hospital Sant Joan de Déu
Barcelona, Spain
Rosa Marqués
Neurological Physiotherapist
Dulce Nombre de María Psychopedagogic Institute
Málaga, Spain
Ángela Pieras
Hospital Pharmacist (Consultant)
Hospital Sant Joan de Déu
Barcelona, Spain
Flor Rolleri
Core Secretary
Menkes International – Copper Rare Foundation
Spain
Mónica Sáez
Hospital Pharmacist
Complejo Hospitalario de León
León, Spain
Rubén Varela
Hospital Pharmacist
Complejo Hospitalario de León
León, Spain
Miquel Villaronga
Hospital Pharmacist (Consultant, retired)
Hospital Sant Joan de Déu
Barcelona, Spain
All CORE Team members serve on a volunteer, pro bono basis.